Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN).

Leukemia · 2023 · PMC10079540 · PMID 36828867

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

1D ): Although significance was not reached, these analyses show a favorable trend for patients without prior cytoreduction, at high-risk for vascular complications, and with the presence of a JAK2 V617F mutation.

also in 661 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.